Alterations in human circulating and bone marrow mononuclear cell polyamine levels in hematologic malignancies as a consequence of difluoromethylornithine administration.
Maddox, A M
Alterations in human circulating and bone marrow mononuclear cell polyamine levels in hematologic malignancies as a consequence of difluoromethylornithine administration. [electronic resource] - Investigational new drugs Jun 1988 - 125-34 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0167-6997
10.1007/BF00195371 doi
Adolescent
Adult
Aged
Biogenic Polyamines--blood
Bone Marrow--analysis
Eflornithine--pharmacology
Female
Humans
Leukemia--blood
Leukocytes, Mononuclear--analysis
Male
Middle Aged
Multiple Myeloma--blood
Alterations in human circulating and bone marrow mononuclear cell polyamine levels in hematologic malignancies as a consequence of difluoromethylornithine administration. [electronic resource] - Investigational new drugs Jun 1988 - 125-34 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0167-6997
10.1007/BF00195371 doi
Adolescent
Adult
Aged
Biogenic Polyamines--blood
Bone Marrow--analysis
Eflornithine--pharmacology
Female
Humans
Leukemia--blood
Leukocytes, Mononuclear--analysis
Male
Middle Aged
Multiple Myeloma--blood